Australia, April 8 -- Caristo Diagnostics Ltd., owns the trademark (2512326) for 'CaRi-Plaque' till June 13, 2034.
Status: protected:
Registered/protected
Classes: 9 [Computer software for use with medical patient monitoring, diagnostic and prognostic equipment for receiving, processing, transmitting, analysing, organising and displaying data; computer software relating to the medical field; imaging apparatus; computer software for medical equipment, including diagnostic and prognostic equipment; none of the aforementioned goods for use in the fields of workplace wellbeing, mental health, occupational psychology, coaching, training, performance monitoring and management, organisational metrics in engagement and culture.], 10 [Medical devices for diagnosis and prognosis of cardiovascular disease; medical devices for diagnosis and prognosis of metabolic disease; medical devices for evaluation of cardiovascular disease; medical devices for the evaluation of metabolic disease; medical apparatus for measuring inflammation in human tissue; medical diagnostic and prognostic apparatus for medical purposes; medical imaging apparatus; medical devices for analysing, storing, transmitting and organising medical data, including data derived from medical scans and medical imaging.], 35 [Compilation of medical reports.], 42 [Software development, programming and implementation in the field of medical imaging; medical and pharmacological research services; medical research; medical research services; scientific investigations for medical purposes; scientific research for medical purposes; software as a service (SaaS) featuring computer software platforms for artificial intelligence; software design and development; software engineering; computer aided diagnostic testing services; computer programming in the medical field; software as a service (SaaS) services featuring software for machine learning, deep learning and deep neural networks; software as a service (SaaS); software as a service (SaaS) related to CT image analysis; software as a service (SaaS) relating to the early detection, diagnosis, prognosis and treatment of disease, including cardiovascular and metabolic disease; information, advisory and consultancy services relating to the aforesaid; none of the aforementioned services provided in respect of workplace wellbeing, mental health, occupational psychology, coaching, training, performance monitoring and management, organisational metrics in engagement and culture.] and 44 [Medical diagnostic and prognostic services; issuing of medical reports; medical analysis for the diagnosis, prognosis and treatment of persons; medical analysis services; medical testing for diagnostic, prognostic or treatment purposes; consulting services relating to health care; human healthcare services; medical imaging services; information, advisory and consultancy services relating to the aforesaid; none of the aforementioned services provided in respect of workplace wellbeing, mental health, occupational psychology, coaching, training, performance monitoring and management, organisational metrics in engagement and culture.]
Type of Mark: Word
Date of Acceptance: Jan. 30
Registration Advertised: April 7
For further details contact J A Kemp LLP .
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2512326.
Disclaimer: Curated by HT Syndication.